Baidu
map

Stroke:脑静脉血栓形成后发生肺栓塞的风险如何?

2017-02-23 xing.T MedSci原创

由此可见,CVT后发生PE的风险明显低于DV后发生PE的风险。在CVT患者中,住院期间发生PE的风险最大。

静脉血栓形成(CVT)是一种静脉血栓栓塞类型。CVT后发生肺栓塞(PE)的风险是否与深静脉血栓形成(DVT)后发生PE的风险相类似仍是未知。近日,卒中领域权威杂志Stroke上发表了一篇研究文章,研究人员旨在评估了CVT后发生PE的风险。

研究人员采用在2005年至2013年期间在美国加利福尼亚、纽约和佛罗里达所有急诊科就诊和住院的行政数据进行了一项回顾性队列研究。研究人员使用之前证实的国际疾病分类第九修订版临床编码确定了CVT或DVT和PE结局。采用Kaplan-Meier生存统计和Cox比例风险模型比较CVT 后发生PE风险与DVT后发生PE的风险。

研究人员确定了4754例CVT患者和241276DVT患者。在平均随访3.4(±2.4)年期间,138例CVT患者和23063例DVT患者发生PE。相比于DVT患者,CVT患者更年轻,更常见于女性,并且血栓栓塞的危险因素更少。住院期间,CVT患者发生PE的发生率为1.4%(95%可信区间[CI]为1.1%-1.8%),而DVT患者发生PE的发生率为6.6%(95%CI为6.5%-6.7%)。到5年后,CVT患者发生PE的累积发生率为3.4%(95%CI为2.9%-4%),而DVT患者为10.9%(95%CI为10.8%-11.0%;P<0.001)。相比于DVT,CVT与较低的PE调整风险比更相关(风险比为0.26;95%CI为0.22-0.31)。

由此可见,CVT后发生PE的风险明显低于DV后发生PE的风险。在CVT患者中,住院期间发生PE的风险最大。       

原始出处:


Ava L. Liberman, et al. Risk of Pulmonary Embolism After Cerebral Venous Thrombosis.Stroke. 2017. https://doi.org/10.1161/STROKEAHA.116.016316

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1697417, encodeId=faaa169e417a3, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Jul 22 11:33:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955267, encodeId=472e195526eb7, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Apr 26 02:33:00 CST 2017, time=2017-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483249, encodeId=15b214832499a, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sat Feb 25 06:33:00 CST 2017, time=2017-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=177765, encodeId=86e71e776511, content=不知抗凝治疗的偏倚有无在文章中讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4cd1660740, createdName=dachengl, createdTime=Fri Feb 24 17:54:49 CST 2017, time=2017-02-24, status=1, ipAttribution=)]
    2017-07-22 fusion
  2. [GetPortalCommentsPageByObjectIdResponse(id=1697417, encodeId=faaa169e417a3, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Jul 22 11:33:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955267, encodeId=472e195526eb7, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Apr 26 02:33:00 CST 2017, time=2017-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483249, encodeId=15b214832499a, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sat Feb 25 06:33:00 CST 2017, time=2017-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=177765, encodeId=86e71e776511, content=不知抗凝治疗的偏倚有无在文章中讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4cd1660740, createdName=dachengl, createdTime=Fri Feb 24 17:54:49 CST 2017, time=2017-02-24, status=1, ipAttribution=)]
    2017-04-26 xue8602
  3. [GetPortalCommentsPageByObjectIdResponse(id=1697417, encodeId=faaa169e417a3, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Jul 22 11:33:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955267, encodeId=472e195526eb7, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Apr 26 02:33:00 CST 2017, time=2017-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483249, encodeId=15b214832499a, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sat Feb 25 06:33:00 CST 2017, time=2017-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=177765, encodeId=86e71e776511, content=不知抗凝治疗的偏倚有无在文章中讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4cd1660740, createdName=dachengl, createdTime=Fri Feb 24 17:54:49 CST 2017, time=2017-02-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1697417, encodeId=faaa169e417a3, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sat Jul 22 11:33:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955267, encodeId=472e195526eb7, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Wed Apr 26 02:33:00 CST 2017, time=2017-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483249, encodeId=15b214832499a, content=<a href='/topic/show?id=c82e991e71b' target=_blank style='color:#2F92EE;'>#静脉血栓形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99177, encryptionId=c82e991e71b, topicName=静脉血栓形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d387907505, createdName=ms5187542471278033, createdTime=Sat Feb 25 06:33:00 CST 2017, time=2017-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=177765, encodeId=86e71e776511, content=不知抗凝治疗的偏倚有无在文章中讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4cd1660740, createdName=dachengl, createdTime=Fri Feb 24 17:54:49 CST 2017, time=2017-02-24, status=1, ipAttribution=)]
    2017-02-24 dachengl

    不知抗凝治疗的偏倚有无在文章中讨论

    0

相关资讯

JAMA Neurol:胖女人小心了,口服避孕药脑静脉血栓形成风险大

近期发表在JAMA Neurology的研究称,口服避孕药的肥胖女性,与没有口服避孕药的正常体重女性相比,脑静脉血栓形成(CVT)的风险更大。CVT是一种罕见的疾病,主要影响年轻的成年人和儿童。CVT与静脉血栓栓塞症(VTE)有相同的危险因素如癌症和口服避孕药,此外CVT还有特定的危险因素如局部感染和头部外伤。荷兰阿姆斯特丹学术医疗中心的Jonathan M. Coutinho博士对来自两家医院的

Stroke:女性脑静脉血栓形成后怀孕安全吗?

妊娠和产褥期与静脉血栓形成事件(VTEs)的风险增加有关,包括脑静脉血栓(CVT)。该研究的目的是系统地审查,在之前患过CVT的妊娠女性中,(1)CVT或其它VTE复发的风险;(2)妊娠的结果;(3)抗血栓的预防与这些结果的相关性。研究人员检索了MEDLINE,Cochrane系统评价数据库,clinicaltrials.gov(从成立到2015年7月),其中包括研究和综述文章的参考文献。研究人员

Baidu
map
Baidu
map
Baidu
map